Latest Tag: Biosafety Resources

In this briefing we respond to the main criticisms of the Seralini GM maize rat study (which have been appearing ad nauseum in the world’s mainstream media); provide some background as to the importance of the NK603 GM maize to the biotechnology industry (and hence the scale of their reaction); and place the attacks on […]

Mariam Mayet attended COP MOP 5 in Nagoya Japan. Indeed, she has been following the Biosafety Protocol discussions since 1999. In this brief, she argues that the Biosafety Protocol lags far behind the biosafety challenges faced by developing countries such as South Africa. She also expresses deep disappointment with the loss of a international civil […]

In this briefing, we present an overview of a new organisation called Biosafety South Africa. Biosafety South Africa was launched early this year, receives funding from the South African government through the Department of Science and Technology. Biosafety South Africa has no legislative mandate to influence GMO decision-making but appears set to carve its niche […]

Haidee Swanby of the African Centre for Biosafety attended a meeting hosted by the African Union during May 2009 in Arusha, Tanzania on various biosafety initiatives of importance to the continent. In this briefing paper Haidee discusses the meeting and the issues and challenges lying ahead for the continent. Read here.

‘Marker Assisted Selection’ uses molecular markers as tools in a plant or animal breeding programme to select for important agricultural traits, such as nutritional quality, drought tolerance, disease and pest resistance. It has been suggested that MAS has the potential to increase food production and help initiate a new Green Revolution in Africa. A much […]

GMO trials in South Africa in 2007: Who is doing what and where? Questions around GMO field trials in South Africa continue to be asked, “Where exactly are they happening, when will there be adequate environmental risk assessment and post-release monitoring, what are the effects on neighbours of GMO field trials and what are the […]

During 13-17 March 2006, the Parties to the Cartagena Protocol Biosafety (‘Biosafety Protocol’) will try, after several previous unsuccessful attempts, to craft minimum standards for a global segregation, traceability and accountability system to apply to the cross border movement of bulk shipments of genetically modified (GM) grain. The mechanisms of such a system will depend […]

Vaccines containing living genetically modified organisms (GMOs) are still at an experimental level in the world today. In South Africa, the first clinical trials for genetically modified (GM) vaccines were approved in 2003. These included several trials for HIV and TB vaccines, while several more applications for trials are pending, including those for other GM […]

African Model Law on Safety in Biotechnology 2007 Read briefing here.

After more than 10 years of genetically modified (GM) crop plants being grown in the world, only South Africa out of 53 countries on the African continent have commercial plantings of genetically modified organisms (GMOs). Nine countries: Burkina Faso; Egypt; Kenya; Morocco; Senegal; South Africa; Tanzania; Zambia; and Zimbabwe have reported field trials of GMOs, […]

Read the article here. By Mariam Mayet African Centre for Biosafety July 2006 The “may contain” labels flood the feed sector. Even transboundary movements which could pass as GM-free under existing legislation for LMO-FFPs are labelled as “may contain”. Grain trade and important ports are leading in this clever move which actually ridicules the Protocol. […]

On the 12th of May 2006 Syngenta South Africa (Pty) Ltd, a subsidiary of Swiss chemical giant Syngenta, notified the public of its intention to seek commodity clearance for its GM maize for the use in the production of ethanol. This is the first GM application for commercial approval in the world for a non-feed, […]